Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2

被引：56
|
作者：
Chen, Sha [1 ]
Wang, Qian [1 ]
Christodoulou, Andriana [4 ]
Mylonas, Nikolaos [4 ]
Bakker, Diane [1 ]
Nederlof, Rianne [5 ,6 ]
Hollmann, Markus W. [1 ]
Weber, Nina C. [1 ]
Coronel, Ruben [2 ]
Wakker, Vincent [3 ]
Christoffels, Vincent M. [3 ]
Andreadou, Ioanna [4 ]
Zuurbier, Coert J. [1 ]
机构：
[1] Univ Amsterdam, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Amsterdam UMC,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Expt Cardiol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[4] Natl & Kapodistrian Univ Athens, Pharmacol Lab, Fac Pharm, Athens, Greece
[5] Heinrich Heine Univ Dusseldorf, Med Fak, Inst Herz & Kreislaufphysiol, Dusseldorf, Germany
[6] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Dusseldorf, Germany
来源：
CIRCULATION | 2023年 / 147卷 / 03期
关键词：
body weight; empagliflozin; glucose; infarct size; ischemia; reperfusion; ketones; sodium-glucose cotransporter 2 inhibitor;
D O I：
10.1161/CIRCULATIONAHA.122.061688
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：276 / 279
页数：4
相关论文
共 50 条
  • [41] The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice
    Mayoux, E.
    Klein, T.
    Grempler, R.
    Michael, M.
    Tahbaz, A.
    Naderali, E. K.
    DIABETIC MEDICINE, 2014, 31 : 66 - 66
  • [42] Lack of Interaction Between the Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin and Hydrochlorothiazide or Torasemide in Patients With T2DM
    Giessmann, Thomas
    Heise, Tim
    Macha, Sreeraj
    Mattheus, Michaela
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2012, 61 : A614 - A615
  • [43] The impact of sodium-glucose cotransporter-2 inhibitors on cardiac function
    Chen, I-Wen
    Weng, Hsiu-Lan
    Hung, Kuo-Chuan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 130 - 131
  • [44] Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications
    Bardia, Amit
    Wai, Mabel
    Fontes, Manuel L.
    CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (01) : 80 - 85
  • [45] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
    Tanna, Monique S.
    Goldberg, Lee R.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
  • [46] Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
    Boutros, Heidi
    Okeagu, Chinwenwa
    Sharma, Aman
    Shaikh, Saad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [47] Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling
    Shentu, Yangping
    Li, Yuyang
    Xie, Shicheng
    Jiang, Huanchang
    Sun, Shicheng
    Lin, Rixu
    Chen, Chaosheng
    Bai, Yongheng
    Zhang, Yu
    Zheng, Chenfei
    Zhou, Ying
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 93
  • [48] Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study
    Liu, Jessica
    Chin-Yee, Benjamin
    Chin-Yee, Ian H.
    Ho, Jenny
    Sadikovic, Bekim
    Hsia, Cyrus C.
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (01) : 103 - 105
  • [49] A Rare Case of Sodium-Glucose Cotransporter-2 Inhibitor-Induced Acute Pancreatitis
    Haddadin, Rakahn
    Tonna, Roger F.
    Iqbal, Humzah
    Valenta, Jordan
    Iraninezhad, Homayon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [50] Sodium-Glucose Cotransporter-2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation
    Chang, Sheng-Nan
    Chen, Jien-Jiun
    Huang, Pang-Shuo
    Wu, Cho-Kai
    Wang, Yi-Chih
    Hwang, Juey-Jen
    Tsai, Chia-Ti
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
12345